Clinical Trial Update: Lenalidomide in Treating Patients With Relapsed Mycosis Fungoides/Sezary Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial update of lenalidomide in relapsed mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma) has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycosis Fungoides
• Sézary Syndrome

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Northwestern University | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2020-11-16